FECK
发表于 2025-3-30 11:26:33
http://reply.papertrans.cn/55/5426/542527/542527_51.png
Matrimony
发表于 2025-3-30 12:46:26
http://reply.papertrans.cn/55/5426/542527/542527_52.png
数量
发表于 2025-3-30 17:48:03
http://reply.papertrans.cn/55/5426/542527/542527_53.png
famine
发表于 2025-3-30 23:49:19
http://reply.papertrans.cn/55/5426/542527/542527_54.png
ZEST
发表于 2025-3-31 03:31:31
http://reply.papertrans.cn/55/5426/542527/542527_55.png
Munificent
发表于 2025-3-31 08:46:35
Defining the Therapeutic Ratio for Intracavernosal Administration of Prostaglandin E1 (Alprostadil)Although intracavernosal administration of prostaglandin E. (PGE.) had been performed since the mid-1980s, few data were available from reliable clinical trials. This study provided a rigorous clinical rationale for the continued use of intracorporal PGE..
cluster
发表于 2025-3-31 11:19:42
http://reply.papertrans.cn/55/5426/542527/542527_57.png
不利
发表于 2025-3-31 17:03:23
http://reply.papertrans.cn/55/5426/542527/542527_58.png
START
发表于 2025-3-31 20:47:59
http://reply.papertrans.cn/55/5426/542527/542527_59.png
变形词
发表于 2025-3-31 23:20:01
Route of Administration Has a Considerable Impact on Clinical Profile: A Comparison of IntraurethraIn the field of erectile dysfunction (ED) therapy, few side-by-side comparative studies are carried out. The data from this clinical trial unequivocally show the superiority of intracorporal alprostadil over the intraurethral formulation.